Publications by authors named "Elisabetta Cretella"

Claim this Profile
C
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Roberta Scafetta, Marco Donato, Carla Gullotta, Alessandra Guarino, Cristina Fiore, Elisabetta Cretella

Breast· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant systemic therapy in early breast cancer and results of a prospective observational multicenter BRIDE study: patients outcome and adherence to guidelines in cancer clinical practice.
Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Elisabetta Cretella

Front Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follow-up of early breast cancer in a public health system: A 2024 AIGOM consensus project.
Stefania Gori, Fiorenza De Rose, Antonella Ferro, Alessandra Fabi, Catia Angiolini, Elisabetta Cretella

Cancer Treat Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.
Eleonora Pagan, Monica Ruggeri, Nadia Bianco, Eraldo Oreste Bucci, Rossella Graffeo, Elisabetta Cretella

Breast· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland.
Karin Ribi, Eleonora Pagan, Isabella Sala, Monica Ruggeri, Nadia Bianco, Elisabetta Cretella

J Cancer Surviv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Oreste Davide Gentilini, Edoardo Botteri, Claudia Sangalli, Viviana Galimberti, Mauro Porpiglia, Elisabetta Cretella

JAMA Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
Benedetta Pellegrino, Chiara Tommasi, Olga Serra, Stefania Gori, Elisabetta Cretella

J Immunother Cancer· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Systemic Therapy in Early Breast Cancer: Results of a Prospective Observational Multicenter BRIDE Study.
Stefania Gori, Alessandra Fabi, Catia Angiolini, Monica Turazza, Piermario Salvini, Elisabetta Cretella

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: Final Results From the Phase 2 METEORA-II Randomized Clinical Trial.
Elisabetta Munzone, Meredith M Regan, Saverio Cinieri, Emilia Montagna, Laura Orlando, Elisabetta Cretella

JAMA Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
Agnese Fabbri, Fabrizio Nelli, Andrea Botticelli, Diana Giannarelli, Eleonora Marrucci, Elisabetta Cretella

Front Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
Nicla La Verde, Giovanna Damia, Ornella Garrone, Daniele Santini, Alessandra Fabi, Elisabetta Cretella

Breast Cancer Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of yUbp8 in Mitochondria and Hypoxia Entangles the Finding of Human Ortholog Usp22 in the Glioblastoma Pseudo-Palisade Microlayer.
Veronica De Luca, Manuela Leo, Elisabetta Cretella, Arianna Montanari, Michele Saliola

Cells· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting steady-state endoxifen plasma concentrations in breast cancer patients by CYP2D6 genotyping or phenotyping. Which approach is more reliable?
Milena Gusella, Felice Pasini, Barbara Corso, Laura Bertolaso, Giovanni De Rosa, Elisabetta Cretella

Pharmacol Res Perspect· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gcn5p and Ubp8p Affect Protein Ubiquitylation and Cell Proliferation by Altering the Fermentative/Respiratory Flux Balance in .
Antonella De Palma, Giulia Fanelli, Elisabetta Cretella, Veronica De Luca, Raffaele Antonio Palladino

mBio· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral anticancer therapy project: Clinical utility of a specific home care nursing programme on behalf of Italian Association of Medical Oncology (AIOM).
Massimo Cirillo, Luciano Carlucci, Lorenzo Legramandi, Editta Baldini, Cosimo Sacco, Elisabetta Cretella

J Clin Nurs· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HERBA Study: A Retrospective Multi-Institutional Italian Study on Patients With Brain Metastases From HER2-Positive Breast Cancer.
Stefania Gori, Fabio Puglisi, Stefano Moroso, Alessandra Fabi, Nicla La Verde, Elisabetta Cretella

Clin Breast Cancer· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
Sara Gagno, Mario Rosario D'Andrea, Mauro Mansutti, Chiara Zanusso, Fabio Puglisi, Elisabetta Cretella

Clin Breast Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
Stefania Gori, Alessandro Inno, Elena Fiorio, Jennifer Foglietta, Antonella Ferro, Elisabetta Cretella

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: The Promher Study: An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer.
Stefania Gori, Alessandro Inno, Elena Fiorio, Jennifer Foglietta, Antonella Ferro, Elisabetta Cretella

PLoS One· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin in cutaneous breast cancer metastasis treatment: clinical activity and symptom control.
Nicla La Verde, Anna Moretti, Gabriella Farina, Maria Chiara Dazzani, Teresa Gamucci, Elisabetta Cretella

Future Oncol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis